Two informational events of interest to SMA researchers and medical professionals
In October, a workshop and a course will be held that may be of interest to researchers and medical professionals involved with spinal muscular atrophy (SMA).
At the beginning of October, the Center for Continuing Medical Education at Columbia University in New York will hold a course to update clinicians and caregivers about therapies in development, the new consensus on patient management, and ways to participate in upcoming clinical trials. Supported by a grant from the New York-based SMA Foundation, “Recent Advances in SMA and Other Pediatric Neuromuscular Diseases” will be held October 2nd and is “an intensive one-day course designed for medical professionals, including physicians, nurses, genetic counselors, physical, occupational, and respiratory therapists, with an interest in pediatric neuromuscular diseases.” For more information about the course, click here.
Later in the month, a three-day workshop (October 18-20) about conducting research on rare diseases and orphan products will be held in Rockville, Maryland. Sponsored by the Food and Drug Administration (FDA), agencies of National Institutes of Health (NIH), the National Organization for Rare Disorders (NORD), and Duke University Medical Center, the “Accelerating Therapies for Rare Diseases” workshop “focuses on FDAs regulatory requirements and the clinical trial issues that are especially relevant to rare disease research.” Speakers will include members of academia, government agencies, and the private sector. For more information about the workshop, click here.
Tags: Food and Drug Administration, National Institutes of Health, National Organization for Rare Disorders, New York, researchers, sma foundation, spinal muscular atrophy, workshop


In this episode of Fighting Back Podcast, we talk with Chad Boerst from Hill-Rom. Hill-Rom is a sponsor of the 
Many thanks to our lead Sponsor 





